Non-Hodgkin’s lymphoma with unspecified histology and indolent characteristics represents a group of slow-growing blood cancers that develop in the lymphatic system, often remaining silent for years before diagnosis. These cancers form when certain white blood cells grow abnormally and create tumors, primarily in lymph nodes but potentially spreading to other organs throughout the body.
Understanding the Disease
Non-Hodgkin’s lymphoma (NHL) is a type of cancer that affects the lymphatic system, which is the body’s network of organs, vessels, and tissues that help fight infections and diseases. This system includes lymph nodes, the spleen, bone marrow, and other organs that work together to protect the body from harmful germs and foreign substances. When NHL develops, certain white blood cells called lymphocytes begin to grow out of control, forming tumors and potentially spreading throughout the body.
The term “indolent” refers to lymphomas that grow and spread very slowly. Unlike aggressive forms of lymphoma that develop quickly and cause symptoms within weeks, indolent lymphomas can exist in the body for months or even years without causing noticeable problems. This slow-growing nature means that many people with indolent lymphoma live with the condition for a long time, though it typically cannot be completely cured once it reaches advanced stages.
When doctors classify a lymphoma as having “unspecified histology,” it means the exact cell type and characteristics have not been fully determined or documented. The lymphatic system contains different types of lymphocytes, mainly B cells and T cells, and each can give rise to different subtypes of lymphoma. Without specific histological identification, treatment approaches may be more general rather than tailored to a particular subtype.
How Common Is This Condition
Non-Hodgkin lymphoma is relatively common among blood cancers. In the United States, approximately 80,620 new cases of NHL are expected to be diagnosed in 2024, making it the eighth most common cancer diagnosis in the country. Worldwide, NHL ranks as the eleventh most common cancer. The disease is significantly more common than its counterpart, Hodgkin lymphoma, accounting for the vast majority of lymphoma cases.
Indolent lymphomas represent a substantial portion of all non-Hodgkin lymphomas, making up between 35 and 45 percent of NHL cases. Among the slow-growing types, follicular lymphoma is the most common, accounting for about 20 percent of all NHL diagnoses in the UK, with approximately 2,300 people diagnosed each year in that country alone. Other indolent types include marginal zone lymphoma, small lymphocytic lymphoma, and certain cases of mantle cell lymphoma.
The average age at diagnosis for indolent lymphoma is around 60 years, though the disease can affect people at any age. It affects both men and women, though statistics show that being male and older increases the risk of developing non-Hodgkin lymphoma. The disease is more prevalent in elderly populations, with risk increasing significantly after age 75 for some subtypes like follicular lymphoma.
What Causes Indolent Non-Hodgkin’s Lymphoma
The exact causes of indolent non-Hodgkin’s lymphoma involve changes in the genetic material inside lymphocytes that occur at some point during a person’s lifetime. These mutations cause the cells to grow abnormally and avoid the normal process of cell death. In follicular lymphoma, for example, about 90 percent of cases involve a specific genetic change called the t(14;18) translocation, which causes overexpression of a protein called BCL2. This protein gives cells anti-apoptotic properties, meaning they resist the natural process that would normally cause damaged or old cells to die.
Various factors can contribute to these genetic changes, though in many cases no specific cause can be identified. Chromosomal translocations, where pieces of genetic material swap places between chromosomes, are frequently found in lymphoma cells. These genetic rearrangements can activate genes that promote cancer growth or turn off genes that normally protect against cancer.
Exposure to certain toxins and chemicals may play a role in some cases. Chronic inflammation in the body can also create an environment where lymphoma cells are more likely to develop. Some infections have been linked to specific types of lymphoma, particularly those affecting the stomach or other organs. The development of lymphoma is a complex process that typically involves multiple factors working together over time.
Who Is at Higher Risk
Several factors can increase a person’s likelihood of developing indolent non-Hodgkin’s lymphoma, though having risk factors does not guarantee someone will develop the disease. Age is one of the most significant risk factors, with most cases diagnosed in people over 60. The risk continues to increase with advancing age, particularly after 75 years.
Having a weakened immune system substantially increases lymphoma risk. This includes people who have received organ transplants and take medications to suppress their immune system, those with HIV/AIDS, and individuals with certain inherited immune deficiency conditions. The immune system normally helps identify and destroy abnormal cells, so when it is compromised, cancer cells may be able to grow unchecked.
Being male increases the risk of developing non-Hodgkin lymphoma compared to being female, though both sexes are affected. Certain autoimmune diseases, where the immune system mistakenly attacks the body’s own tissues, have been associated with higher lymphoma rates. Exposure to specific chemicals, pesticides, or radiation may also contribute to increased risk, though the connection is not always clear for individual cases.
Recognizing the Symptoms
One of the challenging aspects of indolent non-Hodgkin’s lymphoma is that it often causes no noticeable symptoms in its early stages. Because the disease grows so slowly, people may have lymphoma for months or years before they or their doctors discover it. Many cases are found incidentally during medical examinations or tests performed for other reasons.
When symptoms do appear, the most common is painless swelling of lymph nodes. These swellings typically occur in the neck, armpits, or groin, where lymph nodes are located close to the skin surface. The lumps are usually firm and may feel rubbery to the touch. Unlike lymph nodes that swell due to infection, which are often tender and resolve within a few weeks, lymphoma-related swelling persists and gradually increases over time.
Some patients experience what doctors call “B symptoms,” which include three specific problems: unexplained fever that persists, drenching night sweats that soak through bedclothes, and unintentional weight loss of more than 10 percent of total body weight over six months. These symptoms help doctors classify the type and stage of lymphoma. A fever specifically means one that stays above 103 degrees Fahrenheit (39.5 degrees Celsius) for more than two hours despite home treatment or lasts longer than two days without explanation.
Other symptoms depend on where in the body the lymphoma cells are growing. If lymphoma affects the chest, patients might experience chest pain, persistent cough, or trouble breathing. When the abdomen is involved, people may feel pain or swelling in the belly area, a sensation of fullness even without eating much, or early satiety where they feel full after only a small amount of food. Persistent fatigue that does not improve with rest is common, as is feeling generally unwell or experiencing malaise.
Less common presentations include rashes or other skin changes, increased sensitivity to insect bites, generalized itching without visible cause, fluid accumulation in the abdomen or around organs, and fevers without any apparent source. Some people may experience symptoms related to specific organs affected by lymphoma, such as gastrointestinal problems if the digestive tract is involved, or neurological symptoms if the disease reaches the nervous system.
Prevention and Screening
Unfortunately, there are no proven methods to prevent indolent non-Hodgkin’s lymphoma, and no routine screening tests are recommended for people without symptoms or specific risk factors. Unlike some cancers where lifestyle changes can significantly reduce risk, the causes of most lymphomas are not well enough understood to allow for targeted prevention strategies.
For people with certain risk factors, particularly those with weakened immune systems, more vigilant monitoring may be appropriate. This includes regular medical check-ups where doctors can examine lymph nodes and discuss any concerning symptoms. People who have received organ transplants or have conditions requiring long-term immune suppression should maintain close contact with their healthcare providers and report any new lumps or persistent symptoms promptly.
Maintaining overall health may help support the immune system, though this does not specifically prevent lymphoma. This includes eating a balanced diet rich in fruits and vegetables, engaging in regular physical activity, maintaining a healthy weight, avoiding tobacco products, and limiting alcohol consumption. These general health practices support the body’s natural defenses and overall well-being.
Avoiding unnecessary exposure to known risk factors is sensible when possible. This might include minimizing contact with certain pesticides or industrial chemicals, particularly for people who work in agricultural or industrial settings where such exposures are more common. However, for most people, specific exposures that caused their lymphoma cannot be identified, and it is important not to focus on self-blame when a diagnosis occurs.
How the Disease Affects the Body
In indolent non-Hodgkin’s lymphoma, the normal function of the lymphatic system becomes disrupted as abnormal lymphocytes accumulate and form tumors. The lymphatic system normally works as both a circulatory pathway and an immune defense network. Lymph fluid travels through vessels, carrying nutrients, waste products, and immune cells throughout the body. Lymph nodes act as filters, trapping foreign particles and allowing immune cells to destroy harmful microorganisms.
When lymphoma develops, the abnormal lymphocytes multiply in an uncontrolled fashion but do so slowly in indolent forms. These cancer cells typically accumulate in lymph nodes, causing them to enlarge. The nodes may become packed with lymphoma cells, disrupting their normal filtering function. Unlike normal lymphocytes that mature, perform their immune functions, and eventually die in a programmed sequence, lymphoma cells resist the signals that would normally cause them to stop dividing or undergo cell death.
As the disease progresses, lymphoma cells can spread beyond the lymph nodes where they originated. They may travel through the lymphatic vessels to other lymph nodes or enter the bloodstream and reach distant organs. Indolent lymphomas commonly involve the bone marrow, where blood cells are produced. When lymphoma cells infiltrate the bone marrow, they can interfere with the production of normal blood cells, potentially leading to low counts of red blood cells (causing anemia and fatigue), white blood cells (increasing infection risk), or platelets (affecting blood clotting).
The spleen, an organ involved in filtering blood and producing immune cells, may become enlarged as lymphoma cells accumulate there. This enlargement can cause a feeling of fullness or discomfort in the upper left side of the abdomen. Lymphoma can also develop in extranodal sites, meaning places outside the lymph nodes. The digestive tract is a common extranodal location, particularly the stomach, small intestine, and surrounding tissues. Other organs that may be affected include the skin, lungs, liver, and, less commonly, the brain and spinal cord.
The immune system’s function becomes compromised in several ways. The abnormal lymphocytes do not perform normal immune functions, essentially taking up space and resources that should support healthy immune responses. This makes patients more susceptible to infections. Additionally, treatments for lymphoma can further suppress immune function temporarily, requiring careful monitoring and sometimes preventive antibiotics or other measures to reduce infection risk.
Despite these disruptions, the indolent nature of these lymphomas means that the body often continues to function relatively normally for extended periods. Many patients maintain good quality of life for years, particularly between treatment periods. The slow progression allows the body time to adapt to changes, and modern treatments can often control the disease effectively when intervention becomes necessary.
